Loading
Astec LifeSciences Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by GODREJ AGROVET LIMITED, was filed 12 Aug 2022.
Insider Decl.
26
Thresholds
n/a
Buy Volume
€7M
14 ops. · all time
Sell Volume
€176,714
7 ops. · all time
Since the insiders bought
- -30.7%Entry ₹1,903.85 · Close at T+365 ₹1,319.50
- -21.1%Entry ₹1,755.25 · Close at T+365 ₹1,385.00
- -21.7%Entry ₹1,635.90 · Close at T+365 ₹1,280.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Astec LifeSciences Limited Hold (neutral), based on 2 analysts. Average price target: ₹670.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,533 of 26,284 companies
22.3
score / 100
Value21
Quality23
FCF yld-5.6%
Earn yld-5.2%
EV/EBITDA·
ROE-26%
Gross mgn32%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹696.25
Analyst consensus
2 analystsHold
₹600.00Target ₹670.00(-4%)₹740.00
Income statement
Revenue₹4.5B
Gross profit₹1.4B32% margin
EBITDA-₹20M-0% margin
Net income-₹809.2M-15.1% margin
Valuation
PER (forward)63.3x
P/Book4.0x
Beta0.15
Balance sheet & cash
Market cap₹15.5B
Total debt₹4.5B
Free Cash Flow-₹862.4M
Debt / Equity115%
Profitability & ownership
ROE-25.8%
ROA-3.4%
% insiders73.1%
% institutions3.0%
Last declaration on 31 July 2025
Declarations26 total
2,236,191 shares@ ₹890.0074.4% of flowEquity SharesSEBI:513fbd9dc05477d455a4c5d8ef7766f6be1694a1
134,873 shares@ ₹1,094.96100.0% of flowEquity SharesSEBI:b971a75566ee8655269c02c6546e8905d4e88c78
404,782 shares@ ₹1,094.96100.0% of flowEquity SharesSEBI:dc9b30e9273dbe57a3577e3e5e03970250f929d4
134,954 shares@ ₹1,094.96100.0% of flowEquity SharesSEBI:041b9e93210e14f2d32dcc4595363d9240889770
134,954 shares@ ₹1,094.96100.0% of flowEquity SharesSEBI:f99709b4f7ed4b6f33e0ff2eefae12b1d81350af
3,390 shares@ ₹1,407.150147.9% of flowEquity SharesSEBI:5e9b630f72f0038598a2d8ab8d072a0e86605e5e
49,976 shares@ ₹1,894.464.3% of flowEquity SharesSEBI:ef15d08df6d309642be2f3ef08536f67fb0424f3
Canonical exit: 9 Nov 2022 (T+90)
50,060 shares@ ₹1,899.474.4% of flowEquity SharesSEBI:7b13c692422fd13abb5a3e58456980844a0839ac
Canonical exit: 8 Nov 2022 (T+90)
949 shares@ ₹1,859.020.1% of flowEquity SharesSEBI:8f44169235823c683dd84b3f3cda631df1cd2e62
Canonical exit: 1 Nov 2022 (T+90)
13,651 shares@ ₹1,847.911.2% of flowEquity SharesSEBI:f6f3c7697a91a421d0802f1ef4ea3029c73427ba
Canonical exit: 30 Oct 2022 (T+90)
3,943 shares@ ₹1,868.14990.3% of flowEquity SharesSEBI:f41a426676b086d8ba9e4b15eff8731536d8e757
Canonical exit: 31 Oct 2022 (T+90)
117,161 shares@ ₹1,868.1310.1% of flowEquity SharesSEBI:b7f4a59172665393bde49c5f0d115fd504de4772
Canonical exit: 27 Oct 2022 (T+90)
59,298 shares@ ₹1,863.315.1% of flowEquity SharesSEBI:d7fcff0aebc770d401375c4777c2666a9ebbc9a7
Canonical exit: 26 Oct 2022 (T+90)
1,727 shares@ ₹1,681.51017.4% of flowEquity SharesSEBI:18e7c505bc7e22499204011fe6e75d6669968796
Canonical exit: 26 Jun 2022 (T+90)
3,108 shares@ ₹1,681.0113.2% of flowEquity SharesSEBI:7c18ab4b2b87fcd70ea6932d8e76a8fdd886c9b0
Canonical exit: 23 Jun 2022 (T+90)
18,453 shares@ ₹1,703.8279.4% of flowEquity SharesSEBI:9a6ad3b4eda43b49813d103b1ad040664e99fa8f
Canonical exit: 22 Jun 2022 (T+90)
600 shares@ ₹1,597.6650.1% of flowEquity SharesSEBI:01ae6677cb3edc17826d8b2359f1bfa0d9ee442a
Canonical exit: 8 Jun 2022 (T+90)
600 shares@ ₹1,593.9049.9% of flowEquity SharesSEBI:38ed33d1d80bfd8f334c928eb7cffdb773dca652
Canonical exit: 8 Jun 2022 (T+90)
1,000 shares@ ₹1,481.3315.5% of flowEquity SharesSEBI:94f5849b28c2143faa3873dc7c8c6768d24d2753
Canonical exit: 5 Jun 2022 (T+90)
2,390 shares@ ₹1,466.969936.5% of flowEquity SharesSEBI:fcf3857ca315136fe2e66c4b70ce3b88bd651b5b
Canonical exit: 29 May 2022 (T+90)
1,000 shares@ ₹1,530.0028.1% of flowEquity SharesSEBI:275b049df0bd53a032fe6a1ad12868fbda771a1d
1,000 shares@ ₹1,507.5427.7% of flowEquity SharesSEBI:c7f11ea2369fd960203db2dd3c1078eec56a5b9e
1,710 shares@ ₹1,400.680144.2% of flowEquity SharesSEBI:a3862d78874ba896dd33bd752fc96644aad87084
1,500 shares@ ₹1,472.700.020% mcap81.0% of flowEquity SharesSEBI:b5549b656d266d81041e836449c0e83fae5695db
500 shares@ ₹1,300.000.0047% mcap19.0% of flowEquity SharesSEBI:55404a4328500ea6af45f344ce9f925a84249017
25 of 26 declarations
About Astec LifeSciences Limited
At Astec LifeSciences Limited, an Indian health care company listed on the Bombay Stock Exchange, a single shareholder drives the purchases: Godrej Agrovet Limited filed 8 times, 7 of them purchases, and made the three largest in the record: EUR 2,693,876 on July 29, 2022, EUR 1,359,918 on July 28, 2022 and EUR 1,166,058 on August 10, 2022. Insiders hold 73.1% of the capital.
In all, 26 filings, published from 2021 to 2025, come from 11 filers: 14 purchases worth EUR 7,346,997 (median EUR 77,161) and 7 sales worth EUR 176,714 (median EUR 24,810). The sales are small: EUR 53,994 for Balram Singh Yadav on June 6, 2023, EUR 28,537 for Tarun Surya on May 21, 2021 and EUR 28,105 for Ramesh Pingale on November 15, 2021.
Read moreShow less
Between February 28 and March 28, 2022, three insiders bought EUR 550,883 in all. The year 2022 holds 14 of the 26 filings, and none falls in the last twelve months. For the 14 purchases a 90-day result is stored: a median of 11.6%, all positive, recorded past results, not a forecast. Market capitalisation is INR 15.5 billion.
